Immunotech Laboratories, Inc.

IMMB · OTC
Analyze with AI
12/31/2016
12/31/2013
12/31/2009
12/31/2005
Assets
Cash & Equivalents$14$1$5$47
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$0$0$0$0
Total Curr. Assets$14$1$5$47
Property Plant & Equip (Net)$305$354$415$0
Goodwill$0$0$0$0
Intangibles$10,014$10,464$10,014$0
Long-Term Investments$200$200$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$19$3
Total NC Assets$10,519$11,018$10,447$3
Other Assets$0$0$0$0
Total Assets$10,533$11,019$10,452$50
Liabilities
Payables$0$0$450$150
Short-Term Debt$773$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,316$3,233$509$953
Total Curr. Liab.$4,089$3,233$959$1,102
LT Debt$1,646$1,646$1,196$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$1,550$0
Total NC Liab.$1,646$1,646$2,746$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$5,734$4,879$3,704$1,102
Equity
Pref Stock$260$250$0$4
Common Stock$575$453$0$15
Retained Earnings-$4,000-$3,007$0-$36,935
AOCI$0$0$0$0
Other Equity$7,964$8,444$6,748$35,864
Total Equity$4,799$6,140$6,748-$1,052
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$10,533$11,019$10,452$50
Net Debt$2,404$1,645$1,191-$47